What is BuzzRx?
Founded in 2010 as Watertree Health, BuzzRx operates as a mission-driven healthcare technology firm dedicated to making essential medicines more affordable. The company provides a free prescription discount card that enables users to save up to 80% on both brand-name and generic medications. Beyond its core service, BuzzRx distinguishes itself through a strategic alignment with major nonprofit organizations, including Make-A-Wish and the ASPCA. This dual-purpose business model not only facilitates direct financial relief for patients but also generates substantial charitable contributions, having already donated over $7 million to its partners while helping Americans save $1 billion on their healthcare expenses.
How much funding has BuzzRx raised?
BuzzRx has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in BuzzRx
PPP
Public-Private Partnership
What's next for BuzzRx?
With the successful completion of this major enterprise-level funding, BuzzRx is well-positioned to accelerate its operational footprint and enhance its technological infrastructure. The strategic capital will likely be deployed to expand the reach of its prescription discount network, potentially integrating more advanced data analytics to optimize medication pricing and accessibility. As the company moves into its next phase of growth, the focus will remain on deepening its nonprofit partnerships and scaling its impact within the healthcare ecosystem. By maintaining its commitment to health equity, BuzzRx is poised to solidify its role as a critical intermediary in the pharmaceutical supply chain, ensuring that cost remains a secondary concern for patients in need of vital treatments.
See full BuzzRx company page
